Kiniksa Pharmaceuticals, Ltd.: directors' dealings · United States · SEC (Form 4) SEC:kiniksa-pharmaceuticals-ltd-5de949 US US · SEC (Form 4) Mcap 4.2Bn€ Healthcare
Explore the full directors' dealings record of Kiniksa Pharmaceuticals, Ltd., a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Kiniksa Pharmaceuticals, Ltd. has published 14 reports. Market capitalisation: €4.2bn. The latest transaction was reported on 30 June 2022 — Attribution. Among the most active insiders: Ragosa Mark. The full history is openly available.
Financial data FY ended December 2025 · cache
Analyst consensus
8 analysts 57.00 € Target 63.50 €(+16%) 72.00 €
Income statement
Revenue 677.6 M€
Gross profit 370.3 M€ 55% margin
Net income 59.0 M€ 9.7% margin
Valuation
PER (trailing) 60.1x
PER (forward) 31.1x
P/Book 7.3x
Beta 0.17
Balance sheet & cash
Market cap 4.21 Bn€
Total debt 9.5 M€
Free Cash Flow 136.4 M€
Debt / Equity 1%
Profitability & ownership
ROE 13.7%
ROA 8.2%
% insiders 3.6%
% institutions 100.7%
Last declaration on 30 June 2022
Declarations 14 total
Executives ◆ Grant16 SEC
010,000 shares 0
Class A Common Shares
SEC:0001209191-22-039905:0 · 29 Jun 2022
Executives ◇ Options27 SEC
991 shares
Class A Common Share
SEC:0001415889-22-004316:0 · 26 Apr 2022
Executives ◇ Options16 SEC
2,270 shares
Class A Common Share
SEC:0001415889-22-003286:0 · 21 Mar 2022
Executives ◇ Options24 SEC
3,019 shares
Class A Common Share
SEC:0001415889-22-003284:0 · 21 Mar 2022
Executives ◇ Options16 SEC
4,611 shares
Class A Common Share
SEC:0001415889-22-003282:0 · 21 Mar 2022
Executives ◇ Options16 SEC
5,676 shares
Class A Common Share
SEC:0001415889-22-003283:0 · 21 Mar 2022
Executives ◇ Options24 SEC
3,231 shares
Class A Common Share
SEC:0001415889-22-003285:0 · 21 Mar 2022
Executives ◇ Options27 SEC
18,555 shares
Class A Common Share
SEC:0001415889-22-003287:0 · 21 Mar 2022
Executives ◇ Options24 SEC
872 shares
Class A Common Share
SEC:0001179110-22-002325:0 · 16 Mar 2022
Executives ◆ Grant24 SEC
€8,444 868 shares @ €9.7275 0.0002% mcap 100.0% of flow
Class A Common Share
SEC:0001179110-22-002324:0 · 15 Jul 2021
Executives ◇ Options16 SEC
1,725 shares
Class A Common Share
SEC:0001179110-22-002327:0 · 16 Mar 2022
Executives ◆ Grant24 SEC
€9,368 963 shares @ €9.7275 0.0002% mcap 100.0% of flow
Class A Common Share
SEC:0001179110-22-002328:0 · 15 Jul 2021
Executives ◆ Grant32 SEC
€5,425 641 shares @ €8.4639 0.0001% mcap 100.0% of flow
Class A Common Share
SEC:0001179110-22-002329:0 · 30 Jun 2020
Executives ◇ Options27 SEC
6,569 shares
Class A Common Share
SEC:0001179110-22-002326:0 · 16 Mar 2022